Citation Impact
Citing Papers
Does the Evidence Support the Use of Mycophenolate Mofetil Therapeutic Drug Monitoring in Clinical Practice? A Systematic Review
2008
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
Lack of activity of recombinant HIF prolyl hydroxylases (PHDs) on reported non-HIF substrates
2019 StandoutNobel
Stem Cell–Derived Culture Models of Hepatitis E Virus Infection
2018 StandoutNobel
Graft microvascular disease in solid organ transplantation
2014 StandoutNobel
Inherent DNA ‐binding specificities of the HIF ‐1α and HIF ‐2α transcription factors in chromatin
2018 StandoutNobel
Pharmacologic Targeting of Hypoxia-Inducible Factors
2019 StandoutNobel
A randomised controlled trial of Heparin versus EthAnol Lock THerapY for the prevention of Catheter Associated infecTion in Haemodialysis patients – the HEALTHY-CATH trial
2012
The EGLN-HIF O 2 -Sensing System: Multiple Inputs and Feedbacks
2017 StandoutNobel
Regulation of Type II Transmembrane Serine Proteinase TMPRSS6 by Hypoxia-inducible Factors
2010 StandoutNobel
Parenteral Anticoagulants
2012 Standout
Tuning the Transcriptional Response to Hypoxia by Inhibiting Hypoxia-inducible Factor (HIF) Prolyl and Asparaginyl Hydroxylases
2016 StandoutNobel
Pan-Genotype Hepatitis E Virus Replication in Stem Cell–Derived Hepatocellular Systems
2017 StandoutNobel
Observational Study of Need for Thrombolytic Therapy and Incidence of Bacteremia using Taurolidine‐Citrate‐Heparin, Taurolidine‐Citrate and Heparin Catheter Locks in Patients Treated with Hemodialysis
2011
Acute kidney injury
2012 Standout
Necroinflammation in Kidney Disease
2015
Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases
2016 StandoutNobel
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 Standout
Mechanisms of hypoxia signalling: new implications for nephrology
2019 StandoutNobel
Synthetic glycobiology: exploits in the Golgi compartment
2006 StandoutNobel
An Economic Evaluation of rt-PA Locking Solution in Dialysis Catheters
2014
Hepcidin—A Potential Novel Biomarker for Iron Status in Chronic Kidney Disease
2009
Systemic lupus erythematosus
2016
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors: A Potential New Treatment for Anemia in Patients With CKD
2017
Antithrombotic Therapy for VTE Disease
2016 Standout
Survival and transplantation in end-stage renal disease: a prospective study of a multiethnic population
2009
Targeting the hepcidin–ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation
2011
Approaches to Prolong the Use of Uncuffed Hemodialysis Catheters: Results of a Randomized Trial
2011
Reducing Gal expression on the pig organ – a retrospective review
2005
Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival
2013 Standout
A Randomized Double-Blind Controlled Trial of Taurolidine-Citrate Catheter Locks for the Prevention of Bacteremia in Patients Treated With Hemodialysis
2010
Traditional and non-traditional strategies to optimize catheter function: go with more flow
2010
Iron Deficiency and Raised Hepcidin in Idiopathic Pulmonary Arterial Hypertension
2011
Four-Week Studies of Oral Hypoxia-Inducible Factor–Prolyl Hydroxylase Inhibitor GSK1278863 for Treatment of Anemia
2015
HIF prolyl hydroxylase inhibitors for the treatment of renal anaemia and beyond
2015
Mechanisms of Anemia in CKD
2012
Long-term Follow-up of the Hemodialysis Infection Prevention With Polysporin Ointment (HIPPO) Study: A Quality Improvement Report
2011
Chronic kidney disease
2011 Standout
Hypoxia drives glucose transporter 3 expression through hypoxia-inducible transcription factor (HIF)–mediated induction of the long noncoding RNA NICI
2019 StandoutNobel
Antithrombotic Therapy for VTE Disease
2012 Standout
Evidence for a Lack of a Direct Transcriptional Suppression of the Iron Regulatory Peptide Hepcidin by Hypoxia-Inducible Factors
2009
Pharmacological targeting of the HIF hydroxylases – A new field in medicine development
2016 StandoutNobel
A role of PIEZO1 in iron metabolism in mice and humans
2021 StandoutNobel
Executive Summary
2012 Standout
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization
2009
Acute kidney injury
2021 Standout
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Prevention of Tunneled Cuffed Hemodialysis Catheter–Related Dysfunction and Bacteremia by a Neutral-Valve Closed-System Connector: A Single-Center Randomized Controlled Trial
2012
Rituximab is an effective treatment for lupus nephritis and allows a reduction in maintenance steroids
2009
One-Year Results with Extended-Release Tacrolimus/MMF, Tacrolimus/MMF and Cyclosporine/MMF in De Novo Kidney Transplant Recipients
2007
Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin
2009
Ethnicity and renal disease
2005
Optimizing renal replacement therapy in older adults: a framework for making individualized decisions
2011
Chronic kidney disease: global dimension and perspectives
2013 Standout
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Treatment and Prevention of Heparin-Induced Thrombocytopenia
2012
Prevention and management of catheter-related infection in hemodialysis patients
2010
Meta-Analysis of Biochemical and Patient-Level Effects of Calcimimetic Therapy
2006
A Phase III Study of Belatacept‐based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)
2010 Standout
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
2018 Standout
Catheter Management in Hemodialysis Patients
2010
Interventional Nephrology
2013
Systemic lupus erythematosus
2014
Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rate
2009
Lupus nephritis: where are we now?
2010
Molecular Mechanisms of Hepcidin Regulation: Implications for the Anemia of CKD
2010
Multivessel Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention in ESRD
2012
Clinical relevance of human leukocyte antigen antibodies in liver, heart, lung and intestine transplantation
2013
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
2017 Standout
Prevention of Dialysis Catheter Malfunction with Recombinant Tissue Plasminogen Activator
2011
Acute kidney injury associated with glomerular diseases
2019
Management of Acute Coronary Syndrome in Patients with Chronic Kidney Disease: If We Don’t Risk Anything, We Risk Even More
2011
COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology
2020
Systematic Review: Kidney Transplantation Compared With Dialysis in Clinically Relevant Outcomes
2011 Standout
Anemia of Chronic Disease
2005 Standout
Complications of Catheters: Tunneled and Nontunneled
2012
Calcineurin Inhibitors Stimulate and Mycophenolic Acid Inhibits Replication of Hepatitis E Virus
2014
Emergence of Gentamicin-Resistant Bacteremia in Hemodialysis Patients Receiving Gentamicin Lock Catheter Prophylaxis
2010
Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
2020 Standout
A cross-sectional study of the prevalence and associations of iron deficiency in a cohort of patients with chronic obstructive pulmonary disease
2015 StandoutNobel
Iron Homeostasis and Its Interaction with Prolyl Hydroxylases
2009
Impact of Desensitization on Antiviral Immunity in HLA-Sensitized Kidney Transplant Recipients
2017
Serum hepcidin: reference ranges and biochemical correlates in the general population
2011
Comparative Accuracy of Renal Duplex Sonographic Parameters in the Diagnosis of Renal Artery Stenosis: Paired and Unpaired Analysis
2007
Clinical relevance of antibody development in renal transplantation
2013
HLA Class I Antibodies Trigger Increased Adherence of Monocytes to Endothelial Cells by Eliciting an Increase in Endothelial P-Selectin and, Depending on Subclass, by Engaging FcγRs
2013
Chronic Kidney Disease Diagnosis and Management
2019 Standout
Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients
2014
Clinical iron deficiency disturbs normal human responses to hypoxia
2016 StandoutNobel
Hepcidin is a Potential Regulator of Iron Status in Chronic Kidney Disease
2012
Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney disease
2016
Comparison of Tesio and LifeCath Twin Permanent Hemodialysis Catheters: The VyTes Randomized Trial
2014
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
The Role of Immunoglobulin-G Subclasses and C1q in De Novo HLA-DQ Donor-Specific Antibody Kidney Transplantation Outcomes
2013
Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation Candidates
2012
Biofilm-Related Infections: Bridging the Gap between Clinical Management and Fundamental Aspects of Recalcitrance toward Antibiotics
2014 Standout
Hepcidin and iron regulation, 10 years later
2011
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Iron-Deficiency Anemia
2015 Standout
Heparin versus 0.9% sodium chloride intermittent flushing for prevention of occlusion in central venous catheters in adults
2014
2015 ESC Guidelines for the management of infective endocarditis
2015 Standout
KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update
2020 Standout
Effects of vadadustat on hemoglobin concentrations in patients receiving hemodialysis previously treated with erythropoiesis-stimulating agents
2018
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Antimicrobial lock solutions for preventing catheter-related infections in haemodialysis
2018
Treatment of erythropoietin deficiency in mice with systemically administered siRNA
2012 StandoutNobel
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
2020 Standout
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Works of Tom Cairns being referenced
Outcome of Patients with Preformed Donor-Specific Antibodies Following Alemtuzumab Induction and Tacrolimus Monotherapy
2011
Long-term Tesio Catheter Access for Hemodialysis Can Deliver High Dialysis Adequacy with Low Complication Rates
2011
Sodium Citrate Versus Heparin Catheter Locks for Cuffed Central Venous Catheters: A Single-Center Randomized Controlled Trial
2009
Effect of Elective Coronary Angiography on Glomerular Filtration Rate in Patients with Advanced Chronic Kidney Disease
2009
De Novo DQ Donor-Specific Antibodies Are Associated With a Significant Risk of Antibody-Mediated Rejection and Transplant Glomerulopathy
2012
Antibody-Mediated Rejection After Alemtuzumab Induction: Incidence, Risk Factors, and Predictors of Poor Outcome
2011
Bacteremia Associated with Tunneled Hemodialysis Catheters
2009
Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease
2009
C3 Glomerulopathy
2013
Necrotizing and crescentic glomerulonephritis presenting with preserved renal function in patients with underlying multisystem autoimmune disease: a retrospective case series
2014
Steroid Sparing with Tacrolimus and Mycophenolate Mofetil in Renal Transplantation
2004
The Magnitude and Time Course of Changes in Mycophenolic Acid 12-Hour Predose Levels During Antibiotic Therapy in Mycophenolate Mofetil-Based Renal Transplantation
2007
Cardiac Survival after Pre-emptive Coronary Angiography in Transplant Patients and Those Awaiting Transplantation
2011
Mycophenolic Acid 12-h Trough Level Monitoring in Renal Transplantation: Association with Acute Rejection and Toxicity
2005
Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids
2013
Kidney Transplantation With Minimized Maintenance: Alemtuzumab Induction With Tacrolimus Monotherapy—An Open Label, Randomized Trial
2011
Outcome of Renal Transplantation in South Asian Recipients is Similar to that in Non-Asians
2004
Ethnicity and survival on dialysis in west London
2004
Determinants of Mycophenolic Acid Levels After Renal Transplantation
2005
Five Years of Steroid Sparing in Renal Transplantation with Tacrolimus and Mycophenolate Mofetil
2006
Enzymatic removal from various tissues of the galactose alpha 1,3-galactose target antigens of human antispecies antibodies.
1994
Diagnosis of renal transplant artery stenosis by color Doppler ultrasonography.
1990
Hydroxycloroquine blood concentration in lupus nephritis: a determinant of disease outcome?
2017